Citable company snapshot
CME Group's latest SEC-sourced 2026-03-31 period shows $1.88B in revenue and $1.17B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:Revenues | Mar 31, 2026 | $1.88B | $1.65B | +14.0% |
| xbrl:OperatingIncomeLoss | Mar 31, 2026 | $1.31B | $1.02B | +28.5% |
| xbrl:NetIncomeLossAvailableToCommonStockholdersBasic | Mar 31, 2026 | $1.17B | $1.22B | -4.2% |
| xbrl:NetCashProvidedByUsedInOperatingActivities | Mar 31, 2026 | $1.26B | $1.13B | +11.1% |
| Free Cash Flow (computed) | Mar 31, 2026 | $1.24B | $1.10B | +12.4% |
Source: SEC EDGAR XBRL; period Mar 31, 2026; filed Apr 24, 2026; accession 0001156375-26-000020.
Continue research
Follow same-sector companies and source explainers connected to the financials view.
A factual guide to free cash flow — how it is built from the cash flow statement, why presentations differ, and how Aerarium Research shows the source.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to stock-based compensation, how it appears in company filings, and why it connects cash flow to share count.
A factual guide to goodwill, intangible assets, acquisitions, and impairment charges in company financial statements.
